Brought to you by 
Saluda brings in $75mm in late-stage equity financing
12 Jul 2019
Executive Summary
Saluda Medical Pty. Ltd. (neuromodulation device for pain) closed a $75mm undisclosed late-stage equity round from Boston Scientific Corp., Redmile Group, and one other unnamed financial institution investor.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Saluda brings in $75mm in late-stage equity financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice